Urology

Gaps exist in clinician knowledge of gout management

Gaps exist in clinician knowledge of gout management

By

Ample opportunities exist to increase clinician's knowledge of gout identification and management.

Weighing the benefits and harms of transvaginal mesh

Weighing the benefits and harms of transvaginal mesh

By

Low- and moderate-quality evidence suggests no difference between artificial mesh and native tissue repair of vaginal prolapse.

Hematuria evaluation guidelines issued by ACP

Hematuria evaluation guidelines issued by ACP

By

The ACP has released clinical guidelines for the evaluation of hematuria and referral practices.

Reduction in number of men screened for and diagnosed with prostate cancer

Reduction in number of men screened for and diagnosed with prostate cancer

In the United States, the rate of prostate cancer screening is down, and the number of men diagnosed with the disease has also dropped.

Managing benign prostatic hypertrophy with pumpkin seeds

Managing benign prostatic hypertrophy with pumpkin seeds

By

The most common medical use for pumpkin seeds is managing benign prostatic hypertrophy.

Treatment for urinary tract 
infections in the uncircumcised
 male child


Treatment for urinary tract 
infections in the uncircumcised
 male child


Circumcision should be recommended for male, uncircumcised children with recurring UTIs.

UTI/Pyelonephritis


UTI/Pyelonephritis


By

A young girl with recurrent UTIs was diagnosed with a grade-3 VUR and mild hydronephrosis.

High fiber intake may lower kidney stone risk in postmenopausal women

High fiber intake may lower kidney stone risk in postmenopausal women

There were no significant protective effects noted for fiber, fruit, or vegetable intake on the risk of kidney stone recurrence in women with a history of stones.

New drug combo wins FDA approval to treat UTIs, intra-abdominal infections

New drug combo wins FDA approval to treat UTIs, intra-abdominal infections

Ceftolozane/tazobactam is the fourth antibiotic to be FDA approved in 2014

Testicular cancer risk up in Hispanic patients

Testicular cancer risk up in Hispanic patients

A 58% increase in incidence rate per 100,000 has been noted from 1992 to 2010.

Suspect OSA in patients with nocturia

Suspect OSA in patients with nocturia

By

The severity of sleep apnea has been correlated with frequency of nighttime bathroom visits.

Recurrent
 UTI therapies
 assessed

Recurrent
 UTI therapies
 assessed

By

Daily antibiotic use came out on top when compared with several other strategies for managing recurrent urinary tract infections (UTIs).

Nonsurgical option available for Peyronie's disease

Nonsurgical option available for Peyronie's disease

The FDA has approved Xioflex to treat the connective tissue disorder.

Nonantibiotic prophylaxis may reduce recurrent UTIs

Nonantibiotic prophylaxis may reduce recurrent UTIs

Meta-analysis reviews oral immunostimulant OM-89, estrogens, cranberries and acupuncture.

A cocktail for uncomplicated UTI

A cocktail for uncomplicated UTI

A three-part solution with OTC-ingredients can help prevent future urinary tract infections.

Avoiding costly ­diagnostic mistakes

Avoiding costly ­diagnostic mistakes

By

How should a clinician 
handle a difference of 
opinion with the attending physician on duty?

A case study of nocturnal enuresis

A case study of nocturnal enuresis

A healthy and thriving boy aged 8 years, has never been able to achieve complete nighttime dryness since being potty trained at age 3 years.

Simple treatment for pediatric bedwetting

Simple treatment for pediatric bedwetting

When treating a young patient for monosymptomatic enuresis, be sure to assess the physical, emotional, and developmental maturity of the child.

Many women with uncomplicated UTI willing to delay antibiotics

Many women with uncomplicated UTI willing to delay antibiotics

The majority of women who delayed antibiotics for UTI reported spontaneous improvement after one week.

Quantifying proteinuria

Quantifying proteinuria

By

What is the best method to use when quantifying proteinuria in children and adults?

Myrbetriq safe, effective alternative for OAB

Myrbetriq safe, effective alternative for OAB

By

High discontinuation rates with traditional second-line therapies suggest more overactive bladder treatment options are needed.

FDA approves Xofigo for advanced prostate cancer

FDA approves Xofigo for advanced prostate cancer

By

Xofigo has been approved three months ahead of schedule to treat men with metastatic castration-resistant prostate cancer.

AUA: Treating UTIs in primary care saves $2 billion annually

AUA: Treating UTIs in primary care saves $2 billion annually

Patients diagnosed with a UTI in the emergency room paid about $700 more per episode than those treated in an outpatient clinic.

Recognizing and treating low testosterone in men

Recognizing and treating low testosterone in men

There is a direct correlation between testosterone and metabolic syndrome, mental function, libido, erectile dysfunction, bone density, and overall energy.

FDA approves Ravicti for urea cycle disorders

FDA approves Ravicti for urea cycle disorders

Glycerol phenylbutyrate aids in removing accumulated ammonia due to urea cycle disorders.

First OTC drug approved for overactive bladder

First OTC drug approved for overactive bladder

The FDA has approved oxybutynin (Oxytrol, Merck) as the first over-the-counter treatment for women 18 and older with overactive bladder.

FDA expands Botox indication for overactive bladder

FDA expands Botox indication for overactive bladder

The FDA has approved Botox for adults with overactive bladder who can't use or don't respond to anticholinergics.

New paradigms in managing chronic kidney disease

New paradigms in managing chronic kidney disease

To slow the progression to end-stage renal disease, primary-care clinicians must be able to identify, screen, treat, and educate at-risk individuals.

Managing UTIs in women

Managing UTIs in women

Urinalysis and physical exam determine if the infection is complicated or uncomplicated, primary or recurrent and guide treatment strategy.

Myrbetriq approved for overactive bladder

Myrbetriq approved for overactive bladder

Myrbetriq is indicated for adults with overactive to minimize symptoms of frequent urination and urinary incontinence.

Sign Up for Free e-newsletters